Allergy

The average US household spent $645 on OTC products in 2022.

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.

The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.

An FDA-approval of Omalizumab would help reduce allergic reactions among 17 million people in the United States who have confirmed food allergies.

ADP101 is designed to treat allergy to 1 or more of the world’s most significant allergens including cashew, almond, chicken’s egg, cow’s milk, codfish, peanut, pecan, pistachio, salmon, sesame, soy, shrimp, walnut and wheat.

A study found that around 75% of children who had reported experiencing pollen-AR by the ages of 4 or 8 continued to have persisted in their condition until they reached 24 years of age.